Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu
Trial record 86 of 321 for:    FLUTICASONE AND SALMETEROL

Single Blind Cross-over Dose Response Study in Subjects of Two Inhalers of Salmeterol and Fluticasone Propionate

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02232087
Recruitment Status : Completed
First Posted : September 4, 2014
Last Update Posted : January 26, 2015
Information provided by (Responsible Party):

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : October 2014
Actual Study Completion Date : December 2014
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 February 4, 2016
March 2, 2016
2 March 29, 2016
April 28, 2016
3 July 13, 2016
August 26, 2016
4 December 3, 2018
March 29, 2019
5 May 2, 2019
July 19, 2019